On November 28th, 2025, The New York Times featured insights from AFAR Grantee Reisa Sperling, PhD,on a newly recognized rising form of dementia, Limbic-predominant age-related TDP-43 encephalopathy or LATE, a name originally proposed by Dr. Sperling.
Dr. Sperling emphasized the importance of finding therapies specifically for LATE, as those with pure LATE cannot benefit from the latest Alzheimer’s drugs that target amyloid.
Dr. Sperling is a 2003 Paul B. Beeson Emerging Leaders Career Development Award in Aging recipient.
Also picked up by The Seattle Times, read, “A Different Type of Dementia Is Changing What’s Known About Cognitive Decline” here.
